Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Strong short-term momentum backed by a recent operating catalyst: on 2026-05-06 the company raised full-year 2026 guidance for revenue, medical margin, and adjusted EBITDA, while the stock gained about 55% over 21 trading days and continued closing near the top of its range.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Margin Recovery ⢠Negative Cash Flow ⢠Liability Burden AGL's earnings and margins are recovering, but negative cash flow, heavy operating liabilities, and an elevated valuation warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Lower highs ⢠Support tested ⢠Rebound failed Support Level: $86.48â$87.89 Resistance Level: $92.38â$92.60 AGL's last-month decline and lower highs keep the outlook bearish unless it holds $86.48â$87.89 support and reclaims $92.38â$92.60.
Sentiment & News
Key News Insights: ⢠Conference participation ⢠ACO expansion ⢠Patient reach agilon Health is advancing investor outreach while expanding its physician network through Family Practice Center's Senior Health Connect ACO partnership.
AI Summary
Do not form an AGL investment view until the underlying security is confirmed: for AGL Energy, the actionable issue is whether Tomago and other firming assets can earn returns above escalating transition capex amid falling wholesale-price forecasts and FY27 downgrade risk.
Description
agilon health, inc. provides healthcare services for senior patients through primary care physicians in communities across the United States. As of December 31, 2021, the company served about 238,000 senior members, including 186,300 Medicare Advantage members and 51,700 Medicare fee-for-service beneficiaries. Founded in 2016 and based in Austin, Texas, the company adopted its current name in March 2021.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jun 10 | Jun 17 | AGL | Agilon Health, Inc. | Strong short-term momentum backed by a recent operating catalyst: on 2026-05-06 the company raised full-year 2026 guidance for revenue, medical margin, and adjusted EBITDA, while the stock gained about 55% over 21 trading days and continued closing near the top of its range. | Closed | +2.9% |
| May 21 | May 28 | AGL | Agilon Health, Inc. | High-risk but clear short-term momentum catalyst: 2026-05-06 Q1 update beat estimates and raised full-year 2026 guidance for revenue, medical margin, and adjusted EBITDA. Stock surged sharply after earnings and is up about 206% over 21 trading days. | Closed | +12.2% |